24
T. Moore et al.
LETTER
(14) Larsen, A. O.; Leu, W.; Oberhuber, C. N.; Campbell, J. E.;
Hoveyda, A. H. J. Am. Chem. Soc. 2004, 126, 11130.
(15) Gade, L. H.; Cesar, V.; Bellemin-Laponnaz, S. Angew.
Chem. Int. Ed. 2004, 43, 1014.
(16) Merzouk, M.; Williams, N. A. Tetrahedron Lett. submitted
for publication.
recrystallised from hot EtOH; yield 21% (0.42 g). 1H NMR
(400 MHz, D2O): d = 0.94 (3 H, d, 3J = 6.4 Hz), 0.97 [3 H,
d, CH(CH3)2, 3J = 6.4 Hz], 1.57–1.70 (2 H, m), 1.72–1.82 (1
H, m), 3.93–3.99 (1 H, m), 4.59 (1 H, dd, 2J = 15.0 Hz,
3J = 7.9 Hz), 4.71 (1 H, dd, 2J = 15.0 Hz, 3J = 4.8 Hz), 7.63
(5 H, m), 7.79 (1 H, s), 7.99 (1 H, s), 9.45 (1 H, s). 13C NMR
(100 MHz, D2O): d = 21.1, 21.8, 23.8, 38.9, 49.5, 51.2,
122.5 (2 C), 123, 123.5, 130.5 (2 C), 130.6, 137.2. Mp 260–
264 °C. HRMS: m/z calcd for [M – 2 Br – H]+ (C15H22N3):
244.1808; found: 244.1808. Anal. Calcd (%): C, 44.47; H,
5.72; N, 10.37. Found: C, 44.25; H, 5.70; N, 10.22.
Compound 4d: 1-mesitylimidazole (5 mmol, 0.93 g) and (S)-
1-bromo-2-amino-4-methylpentane hydrobromide (5 mmol,
1.3 g) were dissolved in anhyd MeCN (50 mL) and heated to
reflux for 20 h under a nitrogen atmosphere. The solvent was
removed under vacuum and the residue dissolved in MeCN
(3 mL), which was layered with Et2O to precipitate a white
solid. The solid was recrystallised from hot EtOH, yield 20%
(0.36 g). 1H NMR (400 MHz, D2O): d = 0.88 (3 H, d,
3J = 6.6 Hz), 0.93 (3 H, d, 3J = 6.4 Hz), 1.47 (1 H, m), 1.61–
1.73 (2 H, m), 2.02 (3 H, s), 2.03 (3 H, s), 2.31 (3 H, s), 3.92–
3.97 (1 H, m), 4.62 (1 H, dd, 2J = 14.7 Hz, 3J = 6.4 Hz), 4.70
(1 H, dd, 2J = 14.7 Hz, 3J = 6.0 Hz), 7.13 (2 H, s), 7.68 (1 H,
m) 7.87 (1 H, m), 9.18 (1 H, s). 13C NMR (100 MHz, D2O):
d = 16.6 (2 C), 20.3, 21.0, 21.9, 23.8, 39.1, 48.9, 51.5, 123.7,
125.3, 129.5 (2 C), 130.7, 134.8 (2 C), 137.7, 141.8. Mp
264–264.5 °C. HRMS: m/z calcd for [M – 2 Br – H]+:
286.2283; found: 286.2277. Anal. Calcd (%): C, 48.34; H,
6.54; N, 9.39. Found: C, 47.70; H, 6.51; N, 9.15.
Compound 4e: 1-benzylimidazole (8 mmol, 1.26 g) and (S)-
1-bromo-2-amino-3-phenylpropane hydrobromide (5 mmol,
1.48 g) were dissolved in MeCN (30 mL) and heated to
reflux for 20 h. The mixture was then allowed to cool to r.t.
and the product precipitated as a white solid. This was
isolated by filtration and dried under vacuum; yield 32%
(0.74 g). 1H NMR (400 MHz, D2O): d = 3.03 (1 H, dd,
2J = 14.2 Hz, 3J = 8 Hz), 3.12 (1 H, dd, 2J = 14.2 Hz, 3J = 6.6
Hz), 4.10–4.40 (1 H, m), 4.40–4.55 (2 H, m), 5.26 (2 H, s),
7.20–7.50 (12 H, m), 8.72 (1 H, s). 13C NMR (100 MHz,
D2O): d = 36.9, 50.7, 51.7, 53.4, 123.0, 123.3, 128.0, 129.2
(2 C), 129.3 (2 C), 129.4 (2 C), 129.6 (2 C), 129.7, 132.9,
134.1, 136.4. Mp 246–248 °C. HRMS: m/z calcd for [M – 2
Br – H]+ 292.1808; found: 292.1808.
(17) Experimental and Spectroscopic Data for Ligand
Precursors 4a–e
Compound 4a: 1-methylimidazole (5 mmol, 0.4 g) and (S)-
1-bromo-2-amino-4-methylpentane hydrobromide (5 mmol,
1.3 g) were dissolved in anhyd MeCN (50 mL) and heated to
reflux for 20 h under a nitrogen atmosphere. On cooling, a
white solid precipitated and was filtered and dried under
vacuum; yield 40% (0.68 g). 1H NMR (400 MHz, D2O):
d = 0.91 (3 H, d, 3J = 6.6 Hz), 0.95 (3 H, d, 3J = 6.6 Hz),
1.50–1.64 (2 H, m), 1.70–1.80 (1 H, m), 3.85 (1 H, m), 3.91
(3 H, s), 4.48 (1 H, dd, 2J = 15 Hz, 3J = 7.6 Hz), 4.57 (1 H,
dd, 2J = 15 Hz, 3J = 5 Hz), 7.56 (2 H, m), 8.90 (1 H, s). 13
C
NMR (100 MHz, D2O): d = 21.2, 21.9, 23.6, 36.3, 38.8, 49.5,
50.8, 122.9, 124.8, 137.2. Mp 242–244 °C. HRMS: m/z
calcd for [M – 2 Br – H]+ 182.1652; found: 182.1651. Anal.
Calcd (%): C, 35.01; H, 6.17; N, 12.25. Found: C, 34.68; H,
6.13; N, 12.13.
Compound 4b: 1-benzylimidazole (8 mmol, 1.26 g) and (S)-
1-bromo-2-amino-4-methylpentane hydrobromide (5 mmol,
1.3 g) were dissolved in anhyd MeCN (50 mL) and heated to
reflux for 20 h under a nitrogen atmosphere. On cooling, a
white solid precipitated and was filtered and dried under
vacuum; yield 37% (0.79 g). 1H NMR (400 MHz, D2O):
d = 0.86 (3 H, d, 3J = 6.5 Hz), 0.90 (3 H, d, 3J = 6.5 Hz),
1.40–1.69 (3 H, m), 3.79–3.88 (1 H, m), 4.45 (1 H, dd,
2J = 15 Hz, 3J = 7.2 Hz), 4.52 (1 H, dd, 2J = 15 Hz, 3J = 5.5
Hz), 5.41 (2 H, s), 7.45 (5 H, m), 7.59 (2 H, m), 8.97 (1 H,
s). 13C NMR (100 MHz, D2O): d = 21.1, 21.8, 23.8, 38.9,
49.2, 50.9, 53.5, 123.3, 123.6, 129 (2 C), 129.6 (2 C), 129.7,
133.2, 136.7; mp 238.5–240 °C. HRMS: m/z calcd for [M –
2 Br – H]+: 258.1968; found: 258.1965.
Compound 4c: 1-phenylimidazole (5 mmol, 0.72 g, 0.63
mL) and (S)-1-bromo-2-amino-4-methylpentane
hydrobromide (5 mmol, 1.3 g) were dissolved in anhyd
MeCN (50 mL) and heated to reflux for 20 h under a nitrogen
atmosphere. The solvent was removed under vacuum and the
residue dissolved in MeCN (3 mL), and then layered with
Et2O to precipitate a white solid. The solid was
Synlett 2008, No. 1, 21–24 © Thieme Stuttgart · New York